Insights

Gathering insights about Haven…

Similar companies to Haven

Haven Tech Stack

Haven uses 8 technology products and services including WordPress, jQuery, Google Maps, and more. Explore Haven's tech stack below.

WordPress
Content Management System
jQuery
Javascript Libraries
Google Maps
Maps
Amazon Web Services
Platform As A Service
PHP
Programming Languages
Google Tag Manager
Tag Management
Materialize CSS
UI Frameworks
Apache
Web Servers

Media & News

Biohaven Reports First-in-Human Dosing of Oral PKM2 Modulator, BHV-8100, Targeting Metabolic Restoration and Immunomodulation
BHV-8100 is an orally administered, brain-penetrant PKM2 modulator; a novel therapeutic class addressing the bioenergetic and immunometabolic basis of systemic and central nervous system disorders First-in-human study initiated with dose escalation ongoing; preliminary data in healthy participants demonstrates favorable pharmacokinetics supporting convenient, once-daily dosing and well a tolerated profile at projected therapeutic exposures Penetrates blood-brain barrier and reverses metabolic dysfunction with 3-fold improvement in glucose utilization in human, whole brain model (Bexorg BrainEx platform, physiologically reactivated brains from human donors); preferential metabolic rescue in Alzheimer's disease donor brains vs controls Exhibits robust beneficial effects across a spectrum of preclinical models of Alzheimer's, and multiple sclerosis: restores metabolic deficits, reduces inflammation and neurodegeneration, and enhances remyelination PKM2 modulation offers a potential new paradigm for treating large, underserved, and high-value indications in neurology, ophthalmology, and immunology NEW HAVEN, Conn., June 1, 2026 /PRNewswire/ -- Biohaven Ltd.
Jun 01, 2026 | www.prnewswire.com
Biohaven: Despite Today's Gains, I Remain Skeptical
Biohaven Ltd. shared an R&D presentation today in relation to its epilepsy asset and also updated on its degrader programs. BHVN - spun out of the original Biohaven after its acquisition by Pfizer - also has degrader assets focused on autoimmune diseases. Furthermore, there is a Parkinson's program and Obesity program, and some notable catalysts are arriving this year, e.g., pivotal epilepsy topline data.
May 27, 2026 | seekingalpha.com
Biohaven Reports Positive Clinical Biomarker and Patient Data: First MoDE and TRAP Extracellular Protein Degraders Achieve Deep, Rapid, Selective Lowering of Disease-Driving Antibodies in Graves' Disease and IgA Nephropathy
BHV-1300 demonstrated deep, rapid, and sustained lowering of pathogenic TSHR autoantibodies (TSHR-IgG1) in patients with Graves' hyperthyroidism receiving 1000 mg SC weekly, with mean reductions in TSHR-IgG1exceeding >80% over the 12-week study. Participants with Graves' overt hyperthyroidism, confirmed by elevated baseline thyroid tests despite being treated with anti-thyroid drug therapy (ATD), experienced normalization of thyroid hormones within weeks; T4 normalization occurring at a median of 3 weeks and T3 at a median of 5 weeks after the first administration of BHV-1300.
May 27, 2026 | www.prnewswire.com
Biohaven Reports New Clinical Data in Epilepsy with Opakalim, a Selective Kv7.2/7.3 Activator, Highlighting Seizure Control and Markedly Differentiated Tolerability Profile
In a randomized, placebo-controlled, time-to-event trial in idiopathic generalized epilepsy (IGE), the median time to the second day with a generalized tonic-clonic seizure was 141 days in the opakalim 75 mg once-daily treatment group vs. 47 days in the placebo group, representing a 3-fold prolongation.
May 26, 2026 | www.prnewswire.com
Biohaven Ltd. (BHVN) Upgraded to Buy: Here's Why
Biohaven Ltd. (BHVN) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects.
May 05, 2026 | www.zacks.com
Biohaven Reports Recent Business Developments and First Quarter 2026 Financial Results
Biohaven to update clinical, regulatory, and operational progress at annual R&D Day at the upcoming Yale Innovation Summit on May 27, 2026. Advancement of high-value, late-stage priority programs: Pivotal epilepsy program with selective Kv7 ion channel activator, opakalim, with expected topline results in 2H 2026.
May 04, 2026 | www.prnewswire.com
Biohaven: Downgrade To Hold On Troriluzole Setback And Obesity Data 2nd Half 2026
Biohaven Ltd. is downgraded from Strong Buy to Hold following the FDA's Complete Response Letter for troriluzole in Spinocerebellar Ataxia. BHVN pivots focus to three late-stage programs: MODE/TRAP degraders [BHV-1400, BHV-1300], Kv7 activator Opakalim, and myostatin-activin inhibitor taldefgrobep alfa for obesity. Taldefgrobep alfa targets obesity with a novel MOA aiming for fat loss, muscle gain, and improved safety versus GLP-1s; phase 2 POC data is expected in 2H 2026.
Apr 15, 2026 | seekingalpha.com

Haven's Email Address Formats

Haven uses at least 2 format(s):

Haven Email Formats	Example	Percentage
First.Last@haven.com	John.Doe@haven.com	66%
FirstLast@haven.com	JohnDoe@haven.com	23%
FLast@haven.com	JDoe@haven.com	6%
First@haven.com	John@haven.com	5%

Frequently Asked Questions

Where is Haven's headquarters located?

Haven's main headquarters is located at 1 Park Lane Hemel Hempstead, England hp2 4yl United Kingdom. The company has employees across 6 continents, including EuropeNorth AmericaAsia.

What is Haven's phone number?

You can contact Haven's main corporate office by phone at

+44-333-202-****

. For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Haven's stock symbol?

Haven is a publicly traded company; the company's stock symbol is BHVN.

What is Haven's official website and social media links?

Haven's official website is havencareers.co.uk and has social profiles on LinkedIn.

What is Haven's NAICS code?

Haven's NAICS code is 5615 - Travel Arrangement and Reservation Services.

How many employees does Haven have currently?

As of April 2026, Haven has approximately 2.9K employees across 6 continents, including EuropeNorth AmericaAsia. Key team members include Chief Executive Officer: S. P.Ceo & Art Director: A. S.Ceo: J. D.. Explore Haven's employee directory with LeadIQ.

What industry does Haven belong to?

Haven operates in the Travel Arrangements industry.

What technology does Haven use?

Haven's tech stack includes WordPressjQueryGoogle MapsAmazon Web ServicesPHPGoogle Tag ManagerMaterialize CSSApache.

What is Haven's email format?

Haven's email format typically follows the pattern of First.Last@haven.com. Find more Haven email formats with LeadIQ.

When was Haven founded?

Haven was founded in 1964.

Haven

Q: What is Haven's official website and social media links?

Haven's official website is havencareers.co.uk. Haven has social profiles on LinkedIn.

Q: How many employees does Haven have currently?

Haven has approximately 2.9K employees.

Q: What technology does Haven use?

Haven's tech stack includes Google Font API, MySQL, Amazon Web Services, WordPress, Flickity.

Q: What is Haven's NAICS code?

Haven's NAICS code is 5615 (Travel Arrangement and Reservation Services).

Travel ArrangementsEngland, United Kingdom1001-5000 Employees

Haven operates a network of seaside holiday parks across the United Kingdom, with 41 locations along the coastline from Scotland to Cornwall. A central support centre based in Hemel Hempstead, England underpins park operations and service delivery. The parks employ a wide range of roles, from entertainers and reception staff to gardeners, chefs, lifeguards, and other hospitality and maintenance positions, serving guests and park owners alike. 

Haven’s offering centers on providing coastal holiday options with on-site services and activities across multiple regions. The company supports its workforce with opportunities for skill development, qualifications, and flexible working arrangements, enabling career paths within the travel arrangements sector.